OACCW Oaktree Acquisition Corp. Iii Life Sciences
Fundamentals / CIK 0002029769 / USDOaktree Acquisition Corp. Iii Life Sciences reported $208.2M in total assets and net income of $4.34M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open OACCW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$3.36M Operating profit
-
Net Income FY 2025$4.34M GAAP bottom line
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$1.23M Total debt: --
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 |
|---|---|
| Operating Income | -$1.20M |
| Interest Income | $8.48M |
| Net Income | $7.29M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Operating Income | -$2.38M | -$262K | -$457K | -$255K | -$226K | -$270K | -$445K | -$304K |
| Interest Income | $1.93M | $1.87M | $1.85M | $2.04M | $2.19M | $2.14M | $2.10M | $1.59M |
| Net Income | -$453K | $1.60M | $1.39M | $1.79M | $1.97M | $1.87M | $1.66M | $1.38M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 |
|---|---|---|
| Cash & Cash Equivalents | $1.43M | $1.36M |
| Cash & Short-Term Investments | $1.43M | $1.36M |
| Total Current Assets | $1.55M | $1.56M |
| Total Non-Current Assets | $201.6M | $193.7M |
| Total Assets | $203.1M | $195.3M |
| Total Current Liabilities | $1.30M | $727K |
| Total Non-Current Liabilities | $7.02M | $7.02M |
| Total Liabilities | $8.32M | $7.75M |
| Retained Earnings | -$6.77M | -$6.08M |
| Total Stockholders' Equity | -$6.77M | -$6.07M |
| Total Equity | -$6.77M | -$6.07M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.23M | $1.18M | $1.28M | $1.43M | $1.33M | $1.39M | $1.28M | $1.36M |
| Cash & Short-Term Investments | $1.23M | $1.18M | $1.28M | $1.43M | $1.33M | $1.39M | $1.28M | $1.36M |
| Total Current Assets | $1.25M | $1.26M | $1.42M | $1.55M | $1.48M | $1.56M | $1.48M | $1.56M |
| Total Non-Current Assets | $207.0M | $205.3M | $203.4M | $201.6M | $199.8M | $197.6M | $195.8M | $193.7M |
| Total Assets | $208.2M | $206.5M | $204.8M | $203.1M | $201.2M | $199.2M | $197.2M | $195.3M |
| Total Current Liabilities | $3.85M | $1.73M | $1.62M | $1.30M | $1.23M | $1.12M | $1.06M | $727K |
| Total Non-Current Liabilities | $7.02M | $7.02M | $7.02M | $7.02M | $7.02M | $7.02M | $7.02M | $7.02M |
| Total Liabilities | $10.87M | $8.75M | $8.64M | $8.32M | $8.25M | $8.14M | $8.08M | $7.75M |
| Retained Earnings | -$9.62M | -$7.49M | -$7.23M | -$6.77M | -$6.77M | -$6.54M | -$6.52M | -$6.08M |
| Total Stockholders' Equity | -$9.62M | -$7.49M | -$7.23M | -$6.77M | -$6.76M | -$6.54M | -$6.52M | -$6.07M |
| Total Equity | -$9.62M | -$7.49M | -$7.23M | -$6.77M | -$6.76M | -$6.54M | -$6.52M | -$6.07M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 |
|---|---|
| Net Income | $7.29M |
| Operating Cash Flow | -$422K |
| Investing Cash Flow | $500K |
| Financing Cash Flow | $0 |
| Net Change in Cash | $78K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$453K | $1.60M | $1.39M | $1.79M | $1.97M | $1.87M | $1.66M | $1.38M |
| Operating Cash Flow | -$204K | -$97K | -$158K | -$144K | -$57K | -$146K | -$76K | -$90K |
| Investing Cash Flow | -- | -- | -- | -- | -- | -- | -- | -$192.0M |
| Net Change in Cash | $46K | -$97K | -$158K | $106K | -$57K | $104K | -$76K | $1.36M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 |
|---|---|
| Return on Assets (ROA) | 3.6% |
| Current Ratio | 1.19x |
| Quick Ratio | 1.10x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | 2.1% | 3.3% | 3.4% | 3.6% | 3.4% | 2.4% | -- | -- |
| Current Ratio | 0.32x | 0.73x | 0.87x | 1.19x | 1.21x | 1.39x | 1.40x | 2.14x |
| Quick Ratio | 0.32x | 0.68x | 0.79x | 1.10x | 1.08x | 1.24x | 1.21x | 1.87x |
| Net Income Growth (YoY) | -123.0% | -14.4% | -16.0% | +29.7% | -- | -- | -- | -- |